Vitekta Evropska unija - slovenščina - EMA (European Medicines Agency)

vitekta

gilead sciences international ltd - elvitegravir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - vitekta co-upravlja z zaviralec ritonavir povečala proteaze in drugi antiretroviralna sredstva, je indicirano za zdravljenje okužbe človeške imunske pomanjkljivosti-virus-1 (hiv-1) pri odraslih, ki so okuženi s hiv-1 brez znane mutacije povezane z odpornostjo na elvitegravir.

Vistide Evropska unija - slovenščina - EMA (European Medicines Agency)

vistide

gilead sciences international limited - cidofovir - citomegalovirusni retinitis - antivirusi za sistemsko uporabo - zdravilo vistide je indicirano za zdravljenje citomegalovirusnega retinitisa pri bolnikih s sindromom pridobljene imunske pomanjkljivosti (aids) in brez ledvične disfunkcije. zdravilo vistide je treba uporabljati le, če se druga zdravila štejejo za neprimerna.

Tybost Evropska unija - slovenščina - EMA (European Medicines Agency)

tybost

gilead sciences ireland uc - cobicistat - okužbe z virusom hiv - antivirusi za sistemsko uporabo - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

Veklury Evropska unija - slovenščina - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Hepcludex Evropska unija - slovenščina - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirusi za sistemsko uporabo - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.